Alpheus Medical Opens Enrollment in New Clinical Trial for Butterfly Glioblastoma

Summary

Alpheus Medical has opened enrollment in a new clinical trial to evaluate PoMA™ therapy in patients with butterfly glioblastoma, a particularly aggressive form of the disease affecting both cerebral hemispheres, administered prior to standard chemoradiation.